Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

2 excellent ASX dividend shares I’d buy today

There are a number of ASX dividend shares that I believe can deliver investment income growth over the long-term.

Businesses that have committed to paying good dividends to investors could be worth paying attention, both for the payouts and the focus on shareholder returns. Dividends could also signify stability and profitability of the business, which is why I like these two ASX dividend shares:

GQG Partners Inc (ASX: GQG)

GQG describes itself as a global investment boutique that’s based in the US that’s focused on managing active active equity portfolios. At 31 August 2022, it had US$87.4 billion of funds under management (FUM).

It manages money for investors that include many large pension funds, sovereign funds, wealth management firms and other financial institutions around the world.

The company is looking to pay out 90% of its distributable earnings. Its net operating income (which is like the net operating profit), it generated US$174.2 million for the first six months of 2022, above the forecasted amount of net operating income of US$172.9 million.

It achieved net inflows of US$6.3 billion during the first six months of 2022, which outlines how the business could keep growing once investment markets stop being so volatile. The dividend can grow along with the FUM growth, making it one of the interesting ASX dividend shares due to its payout and potential growth.

Commsec has an estimate of 14.4 cents per share for the dividend in 2023, which equates to a dividend yield of 8.7%.

Sonic Healthcare Ltd (ASX: SHL)

Sonic describes itself as a healthcare provider with specialist operations in laboratory medicine and pathology, radiology, general practice medicine and corporate medical services.

I think it’s one of the more defensive businesses on the ASX. I also think it’s one of the most reliable ASX dividend shares. We don’t choose when we’re going to become sick or need treatment. People usually need a diagnosis – Sonic’s services are essential.

Its core business is seeing ongoing revenue growth. For example, excluding COVID testing, revenue rose 2.1% in FY22 compared to FY21, or 5.5% compared to FY19.

I like how the business has made some acquisitions such as Canberra Imaging Group and ProPath. which strengthened its radiology division and its USA anatomical pathology operations.

In FY22 it paid a total dividend per share of $1, which was an increase of 10% compared to FY19.

Looking at Commsec, the dividend estimate for FY23 is $1.03 per share, which would be 4.7% including franking credits.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report — or get it emailed to you — for FREE by CLICKING HERE NOW or the button below.

Unsubscribe anytime. Read our Terms, Financial Services Guide, Privacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, Jaz does not have a financial or commercial interest in any of the companies mentioned.
Skip to content